Lodi S, Phillips A, Touloumi G, Pantazis N, Bucher HC, Babiker A, Chene G, Vanhems P, Porter K, Collaboration C, et al. CD4 decline in seroconverter and seroprevalent individuals in the precombination of antiretroviral therapy era. AIDS. 2010;24:2697–2704.
Wolbers M, Babiker A, Sabin C, Young J, Dorrucci M, Chene G, Mussini C, Porter K, Bucher HC, Collaboration C, et al. Pretreatment CD4 cell slope and progression to AIDS or death in HIV-infected patients initiating antiretroviral therapy—the CASCADE collaboration: a collaboration of 23 cohort studies. PLoS medicine. 2010;7:e1000239.
Lodwick RK, Sabin CA, Porter K, Ledergerber B, van Sighem A, Cozzi-Lepri A, Khaykin P, Mocroft A, Jacobson L, De Wit S, et al. Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per microL in Europe and North America: a pooled cohort observational study. Lancet (London, England). 2010;376:340–345.
Stergiou GS, Nasothimiou EG, Kalogeropoulos PG, Pantazis N, Baibas NM.
The optimal home blood pressure monitoring schedule based on the Didima outcome study. Journal of human hypertension. 2010;24:158.
Lodi S, Guiguet M, Costagliola D, Fisher M, de Luca A, Porter K, Collaboration C.
Kaposi sarcoma incidence and survival among HIV-infected homosexual men after HIV seroconversion. Journal of the National Cancer Institute. 2010;102:784–792.
